Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:monoclonal_antibody |
| gptkbp:activeIngredient |
gptkb:golimumab
|
| gptkbp:ATCCode |
L04AB06
|
| gptkbp:contraindication |
active serious infections
|
| gptkbp:FDAapprovalYear |
2013
|
| gptkbp:form |
solution for infusion
|
| gptkbp:halfLife |
about 12 days
|
| https://www.w3.org/2000/01/rdf-schema#label |
Simponi Aria
|
| gptkbp:indication |
gptkb:psoriatic_arthritis
rheumatoid arthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Janssen_Biotech
|
| gptkbp:mechanismOfAction |
TNF-alpha inhibitor
|
| gptkbp:pregnancyCategory |
B
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
hypertension
infections infusion reactions liver enzyme elevation |
| gptkbp:website |
https://www.simponiaria.com/
|
| gptkbp:bfsParent |
gptkb:golimumab
|
| gptkbp:bfsLayer |
6
|